I quite like this quote from Merchant on patients electing to stay on NTI164 “In all my years of biotech investing I have never seen a circumstance where people elect (and the authorities encourage) to stay on a trial after being on it for +90 weeks!
- Forums
- ASX - By Stock
- NTI
- Ann: Rett Syndrome Patients to Receive NTI164 for 52 Weeks
Ann: Rett Syndrome Patients to Receive NTI164 for 52 Weeks, page-4
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTI (ASX) to my watchlist
|
|||||
Last
7.3¢ |
Change
-0.002(2.67%) |
Mkt cap ! $74.26M |
Open | High | Low | Value | Volume |
7.5¢ | 7.5¢ | 7.3¢ | $23.71K | 324.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 87882 | 7.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.3¢ | 23400 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 87882 | 0.071 |
8 | 411208 | 0.070 |
1 | 14492 | 0.069 |
1 | 39000 | 0.068 |
1 | 289000 | 0.065 |
Price($) | Vol. | No. |
---|---|---|
0.073 | 23400 | 1 |
0.074 | 76821 | 1 |
0.075 | 64182 | 2 |
0.076 | 70422 | 1 |
0.077 | 232000 | 3 |
Last trade - 10.18am 16/08/2024 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online